Home

  • Home
    • » e-Newsletters

UK nurses develop MRSA treatment

Infection Control Monitor, May 6, 2005

Two nurses in the UK recently developed a remarkably successful treatment for methicillin-resistant Staphylococcus aureus (MRSA), reports Medical News Today.

The nurses, who work at two hospitals in Worksop and Mexborough, noticed a high level of MRSA infections at open treatment sites, such as percutaneous endoscopic gastrostomies (PEG), tracheostomies, and central venous catheters. They conducted a nine-patient study, and found that ACTISORB* Silver 220-an antimicrobial wound dressing-devastated MRSA and healed most of the patients' wounds in one week.

The nurses-sisters Kathy Leak and Sue Johnson-decided to test out ACTISORB* Silver 220 because it worked well against MRSA and because it does not deliver silver or other potential toxins into the body.

Infection at PEG sites, where tubes are placed through the abdomen wall to feed the patient, are very common. The infections sometimes last longer than a month.

Most Popular